Administration of IκB‐kinase inhibitor PS1145 enhances apoptosis in DMBA‐induced tumor in male Wistar rats
暂无分享,去创建一个
Shishir K. Gupta | R. Kumar | S. Saxena | A. Sahoo | A. Tiwari | R. Gandham | R. Rajmani | U. Chaturvedi | P. Singh
[1] Asif Ali,et al. Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism , 2014, Journal of Inflammation.
[2] N. Perkins,et al. The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.
[3] T. Jacks,et al. Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop. , 2011, Molecular cell.
[4] R. Kong,et al. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. , 2010, Cancer letters.
[5] M. LeBaron,et al. STAT5 regulation of BCL10 parallels constitutive NFκB activation in lymphoid tumor cells , 2009, Molecular Cancer.
[6] K. Umezawa,et al. Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. , 2009, Current pharmaceutical design.
[7] D. Mandelker,et al. Insights into the oncogenic effects of /PIK3CA/ mutations from the structure of p110α/p85α , 2008, Cell cycle.
[8] A. Barsotti,et al. A role for caspase 2 and PIDD in the process of p53-mediated apoptosis , 2008, Proceedings of the National Academy of Sciences.
[9] H. J. Kim,et al. NF-κB and IKK as therapeutic targets in cancer , 2006, Cell Death and Differentiation.
[10] L. Dang,et al. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. , 2006, Oncogene.
[11] K. Umezawa,et al. Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappaB inhibitor. , 2005, International journal of oncology.
[12] Sudhir V. Shah,et al. p53-dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury* , 2005, Journal of Biological Chemistry.
[13] M. Karin,et al. The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer , 2004 .
[14] J. Adams,et al. Novel IKK inhibitors: β-carbolines , 2003 .
[15] N. Munshi,et al. NF-κB as a Therapeutic Target in Multiple Myeloma* , 2002, The Journal of Biological Chemistry.
[16] M. Karin,et al. Missing Pieces in the NF-κB Puzzle , 2002, Cell.
[17] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[18] Zhao-Qi Wang,et al. Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis. , 2001, Biochimica et biophysica acta.
[19] A. Bürkle. Physiology and pathophysiology of poly(ADP‐ribosyl)ation * , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[20] M. Nuttall. From DNA Damage and Stress Signalling to Cell Death , 2001 .
[21] Weiya Ma,et al. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. , 2001, Cancer research.
[22] A. Baldwin. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.
[23] R. Gaynor,et al. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.
[24] D. Green,et al. p53 Induces Apoptosis by Caspase Activation through Mitochondrial Cytochrome c Release* , 2000, The Journal of Biological Chemistry.
[25] L. Wiesmüller,et al. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53 , 1999, Oncogene.
[26] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[27] Weiya Ma,et al. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. , 1999, Carcinogenesis.
[28] A. Israël,et al. IκB proteins: structure, function and regulation , 1997 .
[29] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[30] A. Balmain,et al. Transgenic mice and squamous multistage skin carcinogenesis , 1995, Cancer and Metastasis Reviews.
[31] G. Wick,et al. Simultaneous determination of cell surface antigens and apoptosis. , 1994, Trends in genetics : TIG.
[32] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[33] H. Wolf,et al. Detection of proliferating cell nuclear antigen in diagnostic histopathology. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] P. Shaw,et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Fletcher,et al. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AGNOR) staining, and histological grading in gastrointestinal stromal tumours , 1992, The Journal of pathology.
[36] D. Boldy,et al. How should we count AgNORS? Proposals for a standardized approach , 1989, The Journal of pathology.
[37] D. Lowy,et al. Carcinogenesis: a fifty-year historical perspective. , 1989, The Journal of investigative dermatology.
[38] E. Arffmann,et al. INFLUENCE OF SURFACE LIPIDS ON SKIN CARCINOGENESIS IN RATS , 1979, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[39] A. Glucksmann,et al. The Influence of Carcinogenic Dosage and of Sex on the Induction of Epitheliomas and Sarcomas in the Dorsal Skin of Rats , 1971, British Journal of Cancer.
[40] R. Singh,et al. Induction of skin tumour using DMBA in wistar Rat and histopathological evaluation , 2011 .
[41] J. Kobos,et al. [Assessment of apoptosis measured with TUNEL in laryngeal cancer]. , 2005, Otolaryngologia polska = The Polish otolaryngology.
[42] B. Gullberg,et al. Estimation of liver tumor volume using different formulas—An experimental study in rats , 2004, Journal of Cancer Research and Clinical Oncology.
[43] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.
[44] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[45] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .